We just received data on a new analyst forecast for $BMY. David Amsellem from Piper Sandler set a price target of 75.0 for BMY.
To track analyst ratings and price targets for $BMY, check out Quiver Quantitative's $BMY forecast page.
Should you buy $BMY?
Some analysts are better than others. To view the past performance of Piper Sandler, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$BMY Price Targets
Multiple analysts have issued price targets for $BMY recently. We have seen 12 analysts offer price targets for $BMY in the last 6 months, with a median target of $60.5.
Here are some recent targets:
- David Amsellem from Piper Sandler set a target price of $75.0 on 02/23/2026
- Emily Field from Barclays set a target price of $75.0 on 02/20/2026
- Mohit Bansal from Wells Fargo set a target price of $60.0 on 02/06/2026
- Geoff Meacham from Citigroup set a target price of $64.0 on 02/06/2026
- Seamus Fernandez from Guggenheim set a target price of $72.0 on 02/06/2026
- David Risinger from Leerink Partners set a target price of $60.0 on 01/13/2026
- Louise Chen from Scotiabank set a target price of $60.0 on 01/09/2026
$BMY Insider Trading Activity
$BMY insiders have traded $BMY stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $BMY stock by insiders over the last 6 months:
- DAVID V ELKINS (EVP, Chief Financial Officer) sold 56,000 shares for an estimated $2,650,480
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BMY Revenue
$BMY had revenues of $12.5B in Q4 2025. This is an increase of 1.3% from the same period in the prior year.
You can track BMY financials on Quiver Quantitative's BMY stock page.
$BMY Congressional Stock Trading
Members of Congress have traded $BMY stock 5 times in the past 6 months. Of those trades, 2 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $BMY stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 2 purchases worth up to $30,000 on 12/19, 11/12 and 1 sale worth up to $15,000 on 10/09.
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$BMY Hedge Fund Activity
We have seen 1,124 institutional investors add shares of $BMY stock to their portfolio, and 1,219 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 65,718,198 shares (-75.4%) from their portfolio in Q4 2025, for an estimated $3,544,839,600
- AQR CAPITAL MANAGEMENT LLC added 16,332,924 shares (+172.6%) to their portfolio in Q4 2025, for an estimated $880,997,920
- CAPITAL INTERNATIONAL INVESTORS removed 11,395,497 shares (-35.2%) from their portfolio in Q4 2025, for an estimated $614,673,108
- JPMORGAN CHASE & CO removed 10,813,011 shares (-12.5%) from their portfolio in Q4 2025, for an estimated $583,253,813
- WELLINGTON MANAGEMENT GROUP LLP removed 10,234,541 shares (-59.7%) from their portfolio in Q4 2025, for an estimated $552,051,141
- MARSHALL WACE, LLP added 9,310,682 shares (+607.1%) to their portfolio in Q4 2025, for an estimated $502,218,187
- PACER ADVISORS, INC. removed 9,304,698 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $501,895,410
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
